FDA finalizes 2014 guidance on informed consent in trials, with more updates coming soon

The FDA on Tues­day fi­nal­ized guid­ance from 2014 to help spon­sors, IRBs and in­ves­ti­ga­tors meet all of their in­formed con­sent re­quire­ments when it comes to clin­i­cal tri­als. But the agency still needs to har­mo­nize this guid­ance with HHS’ Com­mon Rule on gov­ern­ment-fund­ed tri­als from 2018.

The 61-page guid­ance cov­ers every­thing from con­sid­er­a­tions for en­rolling chil­dren in tri­als to ob­tain­ing in­formed con­sent via elec­tron­ic meth­ods.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.